These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PMP22 expression in dermal nerve myelin from patients with CMT1A. Katona I, Wu X, Feely SM, Sottile S, Siskind CE, Miller LJ, Shy ME, Li J. Brain; 2009 Jul; 132(Pt 7):1734-40. PubMed ID: 19447823 [Abstract] [Full Text] [Related]
3. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies. Hanemann CO, Stoll G, D'Urso D, Fricke W, Martin JJ, Van Broeckhoven C, Mancardi GL, Bartke I, Müller HW. J Neurosci Res; 1994 Apr 01; 37(5):654-9. PubMed ID: 8028042 [Abstract] [Full Text] [Related]
8. PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells. Prior R, Silva A, Vangansewinkel T, Idkowiak J, Tharkeshwar AK, Hellings TP, Michailidou I, Vreijling J, Loos M, Koopmans B, Vlek N, Agaser C, Kuipers TB, Michiels C, Rossaert E, Verschoren S, Vermeire W, de Laat V, Dehairs J, Eggermont K, van den Biggelaar D, Bademosi AT, Meunier FA, vandeVen M, Van Damme P, Mei H, Swinnen JV, Lambrichts I, Baas F, Fluiter K, Wolfs E, Van Den Bosch L. Brain; 2024 Sep 03; 147(9):3113-3130. PubMed ID: 38743588 [Abstract] [Full Text] [Related]
9. Charcot-Marie-Tooth disease and related inherited neuropathies. Murakami T, Garcia CA, Reiter LT, Lupski JR. Medicine (Baltimore); 1996 Sep 03; 75(5):233-50. PubMed ID: 8862346 [Abstract] [Full Text] [Related]
11. Improved culture methods to expand Schwann cells with altered growth behaviour from CMT1A patients. Hanemann CO, Rosenbaum C, Kupfer S, Wosch S, Stoegbauer F, Müller HW. Glia; 1998 Jun 03; 23(2):89-98. PubMed ID: 9600378 [Abstract] [Full Text] [Related]
12. Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients. Lee S, Bazick H, Chittoor-Vinod V, Al Salihi MO, Xia G, Notterpek L. Am J Pathol; 2018 Mar 03; 188(3):728-738. PubMed ID: 29246495 [Abstract] [Full Text] [Related]
13. Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice. Lee JS, Lee JY, Song DW, Bae HS, Doo HM, Yu HS, Lee KJ, Kim HK, Hwang H, Kwak G, Kim D, Kim S, Hong YB, Lee JM, Choi BO. Nucleic Acids Res; 2020 Jan 10; 48(1):130-140. PubMed ID: 31713617 [Abstract] [Full Text] [Related]